MacroGenics Inc (NASDAQ:MGNX)
| 22.35 Delayed Data As of 3:59pm ET |  -1.37 / -5.78%Today’s Change | 4.04 Today|||52-Week Range 32.18 | -2.23% Year-to-Date |
Latest MGNX News | Press Releases
No recent news for MacroGenics Inc.
Today’s Trading
| Previous close | 23.72 |
| Today’s open | 23.80 |
| Day’s range | 22.21 - 23.80 |
| Volume | 15,333 |
| Average volume (3 months) | 665,288 |
| Market cap | $1.2B |
Data as of 3:59pm ET, 01/21/2021
Growth & Valuation
| Earnings growth (last year) | +24.64% |
| Earnings growth (this year) | -1.20% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +6.76% |
| P/E ratio | NM |
| Price/Sales | 8.15 |
| Price/Book | 4.37 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| KRYSKrystal Biotech Inc | +0.06 | +0.09% |
| INVAInnoviva Inc | -0.31 | -2.46% |
| KNSAKiniksa Pharmaceutic... | -1.22 | -6.52% |
| CLLSCellectis SA | -1.48 | -4.47% |
Data as of 3:59pm ET, 01/21/2021
Financials
| Next reporting date | March 2, 2021 |
| EPS forecast (this quarter) | -$0.73 |
| Annual revenue (last year) | $64.2M |
| Annual profit (last year) | -$151.8M |
| Net profit margin | -236.51% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Rockville, Maryland |
Forecasts
